InflaRx
IFRX
35 hedge funds and large institutions have $16.1M invested in InflaRx in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 8 closing their positions.
113% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 8
35% more funds holding
Funds holding: 26 → 35 (+9)
5.81% less ownership
Funds ownership: 19.22% → 13.41% (-5.8%)
16% less capital invested
Capital invested by funds: $19.2M → $16.1M (-$3.09M)
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
87% less call options, than puts
Call options by funds: $49K | Put options by funds: $388K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.74M |
| 2 |
Renaissance Technologies
New York
|
+$956K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$616K |
| 4 |
Two Sigma Investments
New York
|
+$432K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$382K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$4.67M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.58M |
| 3 |
O
OrbiMed
New York
|
-$2.52M |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$1.04M |
| 5 |
EP
Eversept Partners
New York
|
-$747K |
IFRX Hedge Fund Activity: Q2 2020 in Review
35 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q2 2020, worth a combined $16.1M — down 16% from $19.2M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new IFRX positions and 8 closed out — a net gain of 9 holders — while 5 added to existing stakes and 12 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.74M. The largest seller was Baker Bros. Advisors, cutting an estimated $4.67M.
- 35 institutional investors held InflaRx (IFRX) as of Q2 2020, up from 26 in Q1 2020.
- Funds reported $16.1M of InflaRx stock for Q2 2020, down 16% quarter-over-quarter.
- 17 funds opened new InflaRx positions in Q2 2020 and 8 closed out, a net change of +9 holders.
- The largest InflaRx buyer in Q2 2020 was Morgan Stanley, an estimated $1.74M added.
- The largest InflaRx seller in Q2 2020 was Baker Bros. Advisors, an estimated $4.67M sold.
Based on aggregated 13F filings for Q2 2020.